160657-87-4

Downstream Products

• 177351-21-2 N-[2-(2,6-Dimethoxy-phenoxy)-ethyl]-N-[7-(2-hydroxy-3-isopropylamino-propoxy)-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl]-formamide 
• 177351-09-6 N-[2-(2,6-Dimethoxy-phenoxy)-ethyl]-N-(7-hydroxy-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-formamide 
• 177351-01-8 N-[2-(2,6-Dimethoxyphenoxy)ethyl]-7-hydroxy-2,3-dihydro-1,4-benzodioxin-2-carboxamide 
• 177351-05-2 3-{[2-(2,6-Dimethoxy-phenoxy)-ethylamino]-methyl}-2,3-dihydro-benzo[1,4]dioxin-6-ol 
• 177351-23-4 N-[2-(2,6-Dimethoxy-phenoxy)-ethyl]-N-(7-{3-[2-(3,4-dimethoxy-phenyl)-ethylamino]-2-hydroxy-propoxy}-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-formamide 
• 177351-22-3 N-[7-(3-tert-Butylamino-2-hydroxy-propoxy)-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl]-N-[2-(2,6-dimethoxy-phenoxy)-ethyl]-formamide 
• 177351-13-2 N-[2-(2,6-Dimethoxy-phenoxy)-ethyl]-N-(7-oxiranylmethoxy-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-formamide 
• 160657-56-7 7-HYDROXY-2-{4-[BIS(4-FLUOROPHENYL)METHYL]PIPERAZIN-1-YLCARBONYL}-1,4-BENZODIOXIN 

Relevant academic research and scientific papers

Substituted heterocyclic compounds, method for preparing and compositions containing same

The invention relates to compounds of formula (I): wherein: R1, R2and R3are as defined in the description, X is as defined in the description, Y represents an oxygen atom, a sulphur atom, a C(H)qgroup, SO or SO2, n is equal to from 0 to 5, A represents a NR5R6group, and medicinal products containing the same which are useful in treating or in preventing melatoninergic disorders.